Literature DB >> 2841426

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

W R Gibb1, A J Lees.   

Abstract

The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3.8% to 12.8% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease.

Entities:  

Mesh:

Year:  1988        PMID: 2841426      PMCID: PMC1033142          DOI: 10.1136/jnnp.51.6.745

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

Authors:  H Bernheimer; W Birkmayer; O Hornykiewicz; K Jellinger; F Seitelberger
Journal:  J Neurol Sci       Date:  1973-12       Impact factor: 3.181

2.  Hallervorden-Spatz syndrome.

Authors:  E C Dooling; W C Schoene; E P Richardson
Journal:  Arch Neurol       Date:  1974-01

3.  Lewy bodies of Parkinson's disease contain neurofilament antigens.

Authors:  J E Goldman; S H Yen; F C Chiu; N S Peress
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

4.  Parkinson's disease in 65 pairs of twins and in a set of quadruplets.

Authors:  C D Ward; R C Duvoisin; S E Ince; J D Nutt; R Eldridge; D B Calne
Journal:  Neurology       Date:  1983-07       Impact factor: 9.910

5.  Lewy bodies in cerebral cortex, report of three cases.

Authors:  K Kosaka
Journal:  Acta Neuropathol       Date:  1978-05-24       Impact factor: 17.088

6.  Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells.

Authors:  A Hirano; L T Kurland; G P Sayre
Journal:  Arch Neurol       Date:  1967-03

7.  Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.

Authors:  A H Rajput; B Rozdilsky; O Hornykiewicz; K Shannak; T Lee; P Seeman
Journal:  Arch Neurol       Date:  1982-10

8.  Joseph disease: a multisystem degenerative disorder of the nervous system.

Authors:  H S Sachdev; L S Forno; C A Kane
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

9.  Aetiology of Parkinson's disease.

Authors:  D B Calne; J W Langston
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

10.  Basal forebrain neurons in the dementia of Parkinson disease.

Authors:  P J Whitehouse; J C Hedreen; C L White; D L Price
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

View more
  851 in total

1.  Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease.

Authors:  K Dujardin; A Duhamel; E Becquet; C Grunberg; L Defebvre; A Destee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 2.  Lewy bodies and dementia.

Authors:  D Galasko
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

3.  The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors:  R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

4.  Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease.

Authors:  D E Riley; T C Chelimsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

5.  T1rho (T1ρ) MR imaging in Alzheimer's disease and Parkinson's disease with and without dementia.

Authors:  Mohammad Haris; Anup Singh; Kejia Cai; Christos Davatzikos; John Q Trojanowski; Elias R Melhem; Christopher M Clark; Arijitt Borthakur
Journal:  J Neurol       Date:  2010-10-07       Impact factor: 4.849

6.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

7.  Amygdala pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; R A de Vos; E N Jansen; J Bohl; K Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies.

Authors:  P N Leigh; A Probst; G E Dale; D P Power; J P Brion; A Dodson; B H Anderton
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 9.  Programmed cell death and new discoveries in the genetics of parkinsonism.

Authors:  Robert E Burke
Journal:  J Neurochem       Date:  2007-12-10       Impact factor: 5.372

10.  Advanced time-series analysis of MEG data as a method to explore olfactory function in healthy controls and Parkinson's disease patients.

Authors:  Sanne Boesveldt; Cornelis J Stam; Dirk L Knol; Jeroen P A Verbunt; Henk W Berendse
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.